Wearable Health Monitor PCBA

4–6 Layer Ultra-Low-Power Flex-Rigid Board for Ambulatory Physiological Sensing

Product Overview

The wearable health monitor PCBA powers smart patches, wrist-worn devices, and chest straps that continuously capture physiological data for days to weeks on a single charge. Our design integrates BLE 5.2 SoCs with integrated analog front-end (AFE) for ECG and bioimpedance, MEMS accelerometer and gyroscope for activity classification and fall detection, and PPG optical sensor front-ends for continuous heart rate and SpO₂ monitoring. Aggressive power gating and duty-cycling strategies achieve sub-100 µA sleep current and under 5 mA active sensing current. Flex-rigid construction at 0.2 mm finished thickness enables skin-conformal wearable patches with medical-adhesive-compatible surface finishes. Manufactured under ISO 13485 with ISO 10993 biocompatibility and IPC-6012 Class 3 medical standards, these wearable boards bridge the gap between consumer convenience and clinical-grade monitoring accuracy.

Key Specifications

PCBA Assembly Challenges

Assembling a wearable health monitor PCBA demands extreme miniaturization and biocompatibility discipline. The 0.2 mm finished board thickness requires specialized thin-board handling — vacuum pick-and-place nozzles must use reduced force and carrier pallets to prevent flexure during component placement. The BLE SoC with integrated AFE uses a 0.35 mm pitch WLCSP package; placement accuracy must be within ±15 µm with nitrogen-atmosphere reflow to prevent oxidation of the fine-pitch solder spheres. PPG sensor integration requires precision alignment of the LED and photodiode with the skin-side optical window — the transparent flex coverlay over the optical zone must be free of scratches, haze, or adhesive residue. Medical-adhesive-compatible surface finishes cannot use nickel-containing ENIG on skin-contact areas due to nickel sensitization concerns; immersion silver or organic solderability preservative (OSP) is used on the patient-facing side. Biocompatibility testing per ISO 10993 validates that all materials meet cytotoxicity, sensitization, and irritation requirements.

Test Strategy

Each wearable health monitor PCBA undergoes on-body-equivalent validation. ECG signal validation uses a calibrated patient simulator across 30–240 BPM with QRS detection accuracy above 99.5% under motion conditions. PPG heart rate validation compares to reference ECG during treadmill protocols from rest to 15 km/h running. Bioimpedance measurement verifies respiration rate detection from 6–40 breaths per minute. 7-day continuous wear testing monitors signal quality drift and skin-contact impedance stability. Battery runtime verification confirms > 120 hours of continuous operation with all sensors active at default duty cycles. ISO 10993 biocompatibility testing includes cytotoxicity (ISO 10993-5), sensitization (ISO 10993-10), and irritation (ISO 10993-23) per 24-hour skin contact duration. Drop testing from 1.2 m and IP67 water-ingress testing verify mechanical robustness for daily wear.

PCB Manufacturing Difficulty

Fabricating the wearable health monitor PCB demands expertise in ultra-thin flex-rigid processing and biocompatible materials. The 0.2 mm total thickness across 4–6 layers requires extreme laminate-thickness control — core and prepreg materials must be specified with ±10% thickness tolerance. The flex-to-rigid transition zone is laser-skived to expose flex layers; depth control within ±15 µm prevents damage to inner copper. Laser-drilled microvias (75 µm) connect the dense WLCSP BGA breakout, requiring via-in-pad with filled-and-capped processing. The PPG optical window area on the flex section uses transparent polyimide coverlay with haze below 2% — any optical defect scatters LED light and degrades SpO₂ accuracy. Finished boards undergo 100% automated optical inspection, flex-cycle endurance to 200,000 bends, X-ray verification of via stacking, and biocompatibility extraction testing per ISO 10993-12 before release to assembly.

More information